flutamide and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

flutamide has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amato, G; Cavallaro, G; Craparo, EF; Di Stefano, M; Fontana, G; Giammona, G; Licciardi, M1

Other Studies

1 other study(ies) available for flutamide and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ArticleYear
PHEA-graft-polybutylmethacrylate copolymer microparticles for delivery of hydrophobic drugs.
    International journal of pharmaceutics, 2012, Aug-20, Volume: 433, Issue:1-2

    Topics: Adhesiveness; Androgen Antagonists; Beclomethasone; Caco-2 Cells; Cell Line; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Emulsions; Flutamide; Glucocorticoids; Humans; Hydrophobic and Hydrophilic Interactions; Microspheres; Nanoparticles; Particle Size; Peptides; Polymethacrylic Acids; Solvents; Time Factors

2012